Xavier Deschênes‐Simard

2.4k citations
18 papers · 1.8k indexed · 1 hit paper · h-index 11
Topics
Telomeres, Telomerase, and Senescence (5 papers)Melanoma and MAPK Pathways (3 papers)CAR-T cell therapy research (2 papers)

In The Last Decade

Xavier Deschênes‐Simard

17 papers receiving 1.8k citations

Hit Papers

Metformin inhibits the senescence‐associated secretory ph...20132026201720212013100200300400

Peers

Xavier Deschênes‐Simard
Comparison fields: 5 of 96
  • Molecular Biology 1.0k
  • Physiology 655
  • Oncology 368
  • Immunology 300
  • Cancer Research 255
Replace Fatouma Alimirah with:
Fatouma Alimirah United States
Dominick G. A. Burton United Kingdom
Jingyi Gong United States
Kimberly J. Krager United States
Nikolay Patrushev United States
Husheng Ding United States
Denis Féliers United States
Ali Javaheri United States
Lucilla Luzi Italy
Alison Finigan United Kingdom
Xavier Deschênes‐Simard relative to Fatouma Alimirah United States Fatouma Alimirah's profile →
Citations per field
00.5×1.5×1.9×
Fatouma Alimirah · 1×
Citations per year

Countries citing papers authored by Xavier Deschênes‐Simard

Since Specialization
Citations

This map shows the geographic impact of Xavier Deschênes‐Simard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Deschênes‐Simard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Deschênes‐Simard more than expected).

Fields of papers citing papers by Xavier Deschênes‐Simard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Deschênes‐Simard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Deschênes‐Simard. The network helps show where Xavier Deschênes‐Simard may publish in the future.

Co-authorship network of co-authors of Xavier Deschênes‐Simard

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Deschênes‐Simard. A scholar is included among the top collaborators of Xavier Deschênes‐Simard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Deschênes‐Simard. Xavier Deschênes‐Simard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 12
2 0
3 2
4 8
5 10
6 44
7 34
8 111
9 1
10 3
11 43
12 2
13 172
14
Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activationbreakdown →
486
15 147
16 288
17 298
18 114

About Xavier Deschênes‐Simard

Xavier Deschênes‐Simard is a scholar working on Oncology, Toxicology and Internal Medicine, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (5 papers), Melanoma and MAPK Pathways (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Aging (148 citations), Physiology (655 citations) and Cancer Research (255 citations). Xavier Deschênes‐Simard has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Gerardo Ferbeyre, Olga Moiseeva, Véronique Bourdeau, Michaël Pollak, Sebastian Igelmann, Geneviève Huot, Antoine E. Roux, Sylvain Meloche, Filippos Kottakis and Benoı̂t Viollet. Their work appears in journals such as Genes & Development, Blood and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026